IN2012DN01292A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01292A IN2012DN01292A IN1292DEN2012A IN2012DN01292A IN 2012DN01292 A IN2012DN01292 A IN 2012DN01292A IN 1292DEN2012 A IN1292DEN2012 A IN 1292DEN2012A IN 2012DN01292 A IN2012DN01292 A IN 2012DN01292A
- Authority
- IN
- India
- Prior art keywords
- therapy
- preparing
- processes
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Abstract
The invention relates to the compound of formula (I) in a crystalline anhydrate form, pharmaceutical formulations containing them, their use in therapy and processes for preparing the same.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23743509P | 2009-08-27 | 2009-08-27 | |
PCT/EP2010/062420 WO2011023733A1 (en) | 2009-08-27 | 2010-08-25 | Anhydrate forms of a pyridine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN01292A true IN2012DN01292A (en) | 2015-06-05 |
Family
ID=42790943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1292DEN2012 IN2012DN01292A (en) | 2009-08-27 | 2010-08-25 |
Country Status (18)
Country | Link |
---|---|
US (1) | US8796269B2 (en) |
EP (1) | EP2470545B1 (en) |
JP (3) | JP2013503134A (en) |
KR (1) | KR20120056258A (en) |
CN (1) | CN102639536B (en) |
AU (1) | AU2010288502B2 (en) |
BR (1) | BR112012003435A2 (en) |
CA (1) | CA2772168C (en) |
DK (1) | DK2470545T3 (en) |
EA (1) | EA021411B1 (en) |
ES (1) | ES2440938T3 (en) |
IL (1) | IL217922A (en) |
IN (1) | IN2012DN01292A (en) |
MX (1) | MX2012002369A (en) |
PL (1) | PL2470545T3 (en) |
SG (1) | SG178231A1 (en) |
WO (1) | WO2011023733A1 (en) |
ZA (1) | ZA201200812B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112012003435A2 (en) * | 2009-08-27 | 2016-02-23 | Glaxosmithkline Llc | anhydrous forms of a pyridine derivative |
EP3160469B1 (en) * | 2014-06-25 | 2021-04-28 | Emory University | Methods of managing conditioned fear with neurokinin receptor antagonists |
PL3297631T3 (en) * | 2015-05-18 | 2020-03-31 | Nerre Therapeutics Limited | Nk-1/nk-3 receptor antagonist for the treatment of hot flushes |
KR20190091455A (en) * | 2016-12-15 | 2019-08-06 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | NRF2 Compound |
PT3765024T (en) * | 2018-03-14 | 2024-02-19 | Kandy Therapeutics Ltd | Novel pharmaceutical formulation comprising dual nk-1/nk-3 receptor antagonists |
WO2021030335A1 (en) * | 2019-08-12 | 2021-02-18 | Millendo Therapeutics, Inc. | A stereoisomerically pure nk-3 receptor antagonist and crystalline forms thereof |
CR20220213A (en) | 2019-11-15 | 2022-07-08 | Kandy Therapeutics Ltd | New chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of nt-814 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1035115T3 (en) * | 1999-02-24 | 2005-01-24 | Hoffmann La Roche | 4-phenylpyridine derivatives and their use as NK-1 receptor antagonists |
GB0203022D0 (en) * | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
CA2514037C (en) * | 2003-01-31 | 2012-03-13 | F. Hoffmann-La Roche Ag | Crystalline modification of 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-n-methyl-isobutyramide |
NZ544244A (en) * | 2003-07-03 | 2008-10-31 | Hoffmann La Roche | Dual NK1/NK3 antagonists for treating schizophrenia |
SI1928886T1 (en) | 2005-09-09 | 2011-08-31 | Glaxosmithkline Llc | Pyridine derivatives and their use in the treatment of psychotic disorders |
KR20100101051A (en) * | 2007-12-11 | 2010-09-16 | 씨아이피엘에이 엘티디. | Crystalline polymorphic forms of zopiclone, processes for their preparation and their pharmaceutical compositions |
GB0814340D0 (en) * | 2008-08-05 | 2008-09-10 | Smithkline Beecham Corp | Anhydrous crystol form fo a pyridine derivative |
BR112012003435A2 (en) * | 2009-08-27 | 2016-02-23 | Glaxosmithkline Llc | anhydrous forms of a pyridine derivative |
JP6342662B2 (en) * | 2014-01-29 | 2018-06-13 | 京セラ株式会社 | Drill and method of manufacturing cut product using the same |
-
2010
- 2010-08-25 BR BR112012003435A patent/BR112012003435A2/en not_active Application Discontinuation
- 2010-08-25 CA CA2772168A patent/CA2772168C/en active Active
- 2010-08-25 MX MX2012002369A patent/MX2012002369A/en active IP Right Grant
- 2010-08-25 AU AU2010288502A patent/AU2010288502B2/en active Active
- 2010-08-25 US US13/389,525 patent/US8796269B2/en active Active
- 2010-08-25 KR KR1020127004865A patent/KR20120056258A/en not_active Application Discontinuation
- 2010-08-25 JP JP2012526048A patent/JP2013503134A/en active Pending
- 2010-08-25 EA EA201270302A patent/EA021411B1/en not_active IP Right Cessation
- 2010-08-25 ES ES10747619.4T patent/ES2440938T3/en active Active
- 2010-08-25 CN CN201080037918.3A patent/CN102639536B/en active Active
- 2010-08-25 WO PCT/EP2010/062420 patent/WO2011023733A1/en active Application Filing
- 2010-08-25 EP EP10747619.4A patent/EP2470545B1/en active Active
- 2010-08-25 IN IN1292DEN2012 patent/IN2012DN01292A/en unknown
- 2010-08-25 DK DK10747619.4T patent/DK2470545T3/en active
- 2010-08-25 PL PL10747619T patent/PL2470545T3/en unknown
- 2010-08-25 SG SG2012007464A patent/SG178231A1/en unknown
-
2012
- 2012-02-02 ZA ZA2012/00812A patent/ZA201200812B/en unknown
- 2012-02-02 IL IL217922A patent/IL217922A/en active IP Right Grant
-
2015
- 2015-07-13 JP JP2015139845A patent/JP6404186B2/en active Active
-
2017
- 2017-06-09 JP JP2017114602A patent/JP2017193564A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2440938T3 (en) | 2014-01-31 |
MX2012002369A (en) | 2012-03-29 |
JP2016000739A (en) | 2016-01-07 |
EA201270302A1 (en) | 2012-07-30 |
WO2011023733A1 (en) | 2011-03-03 |
KR20120056258A (en) | 2012-06-01 |
EP2470545A1 (en) | 2012-07-04 |
IL217922A0 (en) | 2012-03-29 |
SG178231A1 (en) | 2012-03-29 |
CN102639536B (en) | 2015-03-18 |
EP2470545B1 (en) | 2013-10-09 |
PL2470545T3 (en) | 2014-03-31 |
JP2017193564A (en) | 2017-10-26 |
JP6404186B2 (en) | 2018-10-10 |
BR112012003435A2 (en) | 2016-02-23 |
ZA201200812B (en) | 2013-03-27 |
AU2010288502A1 (en) | 2012-02-23 |
US20120157450A1 (en) | 2012-06-21 |
AU2010288502B2 (en) | 2013-12-12 |
US8796269B2 (en) | 2014-08-05 |
EA021411B1 (en) | 2015-06-30 |
CA2772168A1 (en) | 2011-03-03 |
CA2772168C (en) | 2019-01-08 |
DK2470545T3 (en) | 2014-01-13 |
JP2013503134A (en) | 2013-01-31 |
CN102639536A (en) | 2012-08-15 |
IL217922A (en) | 2016-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011011661A (en) | Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750. | |
MX2011008864A (en) | Sulfonylated tetrahydroazolopyrazines and their use as medicinal products. | |
MY149731A (en) | Compounds | |
NZ608116A (en) | Triazine-oxadiazoles | |
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
UA109010C2 (en) | Morpholino pyrividines and their use in therapy | |
MX2012013274A (en) | Novel pyrimidine derivatives. | |
MX2010002461A (en) | (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament. | |
IN2014CN04530A (en) | ||
MX2010002419A (en) | (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament. | |
IN2012DN03182A (en) | ||
MY187718A (en) | Pharmaceutical formulations | |
MX2013010898A (en) | Novel pyrimidine derivatives. | |
IN2012DN02139A (en) | ||
MX2010002210A (en) | Catecholamine derivatives and prodrugs thereof. | |
IN2015DN01119A (en) | ||
IN2012DN01292A (en) | ||
JO2682B1 (en) | 7-ALkynyl-1,8-Naphthyridone Derivatives, Preparation Thereof And Therapeutic Use Thereof | |
MX2011011776A (en) | Triptolide prodrugs. | |
UA110128C2 (en) | Normal;heading 1;heading 2;heading 3;INDOLECARBOXAMIDES AND BENZIMIDAZOLECARBOXAMIDES AS INSECTICIDES AND ACARICIDES | |
MY161749A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
MX2012007253A (en) | Tricyclic derivatives and their pharmaceutical use and compositions. | |
MX2011008126A (en) | Substituted indole compounds as bradykinin receptor 1 modulators. | |
MY150428A (en) | Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |